News

Pharmabiz19h
Spectra Medical introduces EndoliftX, a microfiber based non-surgical aesthetic treatment in India
Spectra Medical introduces EndoliftX, a microfiber based non-surgical aesthetic treatment in India: Our Bureau, Mumbai ...
Pharmabiz15h
Intuitive and HSSC come together to strengthen India’s healthcare workforce
Intuitive and HSSC come together to strengthen India’s healthcare workforce: Our Bureau, Mumbai Wednesday, April 30, 2025, 17 ...
Pharmabiz17h
ASPA moots forming action group to strengthen presence in MEA
ASPA moots forming action group to strengthen presence in MEA: Our Bureau, New Delhi Wednesday, April 30, 2025, 15:30 Hrs ...
Pharmabiz14h
Strides strengthens anti-inflammatory portfolio with US FDA approval for celecoxib capsules 100 mg, 200 mg, & 400 mg
Strides strengthens anti-inflammatory portfolio with US FDA approval for celecoxib capsules 100 mg, 200 mg, & 400 mg: Our Bureau, Bengaluru Wednesday, April 30, 2025, 17:45 Hrs [I ...
Pharmabiz14h
Alcresta Therapeutics announces MGH enrols first patient in clinical trial evaluating use of RELiZORB in pancreatitis patients
Alcresta Therapeutics announces MGH enrols first patient in clinical trial evaluating use of RELiZORB in pancreatitis patients: Waltham, Massachusetts Wednesday, April 30, 2025, 1 ...
Pharmabiz21h
US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer
US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...
Pharmabiz20h
Bayer begins phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma
Bayer begins phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma: Berlin Wednesday, April 30, 2025, 12:00 Hrs [IS ...
Pharmabiz18h
Boehringer’s new zongertinib data demonstrates durable and clinically meaningful results in patients with HER2 (ERBB2)-mutant advanced NSCLC
Ingelheim, Germany Wednesday, April 30, 2025, 14:00 Hrs [IST] ...
Pharmabiz16h
AI will revolutionize industry practices and create new business models: ‘KPMG global tech report: Life sciences insights’
Life sciences leads all industries surveyed in prioritizing and investing in edge and quantum computing, VR/AR/XR, spatial computing, XaaS technology and modern delivery. Globally, the life sciences ...
Pharmabiz16h
Signify & SELCO Foundation team-up to solarize 10 24x7 primary health centres in Karnataka under the ‘Swasthya Kiran’ CSR initiative
Signify & SELCO Foundation team-up to solarize 10 24x7 primary health centres in Karnataka under the ‘Swasthya Kiran’ CSR initiative: Our Bureau, Bengaluru Wednesday, April 30 ...
Pharmabiz19h
EMA committee recommends approval of AstraZeneca’s fixed-duration Calquence-based regimens for 1st-line chronic lymphocytic leukaemia
EMA committee recommends approval of AstraZeneca’s fixed-duration Calquence-based regimens for 1st-line chronic lymphocytic leukaemia: Cambridge, UK Wednesday, April 30, 2025, 1 ...
Pharmabiz16h
UK MHRA grants marketing approval for BridgeBio Pharma’s Beyonttra to treat ATTR-CM
UK MHRA grants marketing approval for BridgeBio Pharma’s Beyonttra to treat ATTR-CM: Palo Alto, California Wednesday, April 30, 2025, 16:00 Hrs [IST] BridgeBio Pharma, Inc., a n ...